Creo Medical Group (CREO) Competitors GBX 13.67 -0.08 (-0.61%) As of 08/22/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock CREO vs. EKF, IUG, NCYT, IHC, POLX, AVO, RUA, SUN, MHC, and BELLShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), and Belluscura (BELL). These companies are all part of the "medical devices" industry. Creo Medical Group vs. Its Competitors EKF Diagnostics Intelligent Ultrasound Group Novacyt Inspiration Healthcare Group Polarean Imaging Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group MyHealthChecked Belluscura Creo Medical Group (LON:CREO) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment. Which has better valuation & earnings, CREO or EKF? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreo Medical Group£33.87M1.63-£25.04M-£6.32-2.16EKF Diagnostics£49.91M2.44£4.68M£1.0725.51 Does the media refer more to CREO or EKF? In the previous week, Creo Medical Group and Creo Medical Group both had 1 articles in the media. EKF Diagnostics' average media sentiment score of 1.16 beat Creo Medical Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Creo Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EKF Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in CREO or EKF? 56.1% of Creo Medical Group shares are owned by institutional investors. Comparatively, 70.3% of EKF Diagnostics shares are owned by institutional investors. 22.4% of Creo Medical Group shares are owned by insiders. Comparatively, 5.2% of EKF Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, CREO or EKF? Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Is CREO or EKF more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.03% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Creo Medical Group-73.93% -41.79% -20.09% EKF Diagnostics 9.37%7.03%5.27% SummaryEKF Diagnostics beats Creo Medical Group on 10 of the 12 factors compared between the two stocks. Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CREO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£55.25M£3.59B£5.75B£3.22BDividend YieldN/A2.44%4.40%5.04%P/E Ratio-2.1678.0031.28164.70Price / Sales1.63100.78433.91310,111.42Price / Cash2.4315.9937.7327.93Price / Book1.043.919.535.91Net Income-£25.04M£132.05M£3.26B£5.89B7 Day Performance-0.61%1.22%2.13%49.52%1 Month Performance-2.39%0.37%2.81%56.36%1 Year Performance-52.88%9.08%30.68%136.20% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 13.67-0.6%N/A-52.6%£55.25M£33.87M-2.16279EKFEKF DiagnosticsN/AGBX 25.90-4.3%N/A+1.5%£115.12M£49.91M24.10356Positive NewsIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165NCYTNovacytN/AGBX 40.15-2.2%N/A-63.5%£27.74M£18.12M-0.74120IHCInspiration Healthcare GroupN/AGBX 22.80+8.6%N/A-14.3%£19.75M£42.87M-1.56224Gap DownHigh Trading VolumePOLXPolarean ImagingN/AGBX 0.93+1.0%N/A-48.4%£13.71M£5.21M-0.2428Gap UpAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.33-6.5%N/A+7.0%£7.03M£4.05M-2.6448Gap DownSUNSurgical Innovations GroupN/AGBX 0.67-4.9%N/A-4.9%£6.21M£12.54M-21.1180Gap DownMHCMyHealthCheckedN/AGBX 10.78+2.6%N/A-3.2%£5.61M£9.43M-5.3816Gap UpBELLBelluscuraN/AGBX 0.75flatN/AN/A£1.89M£2.87M-0.0824 Related Companies and Tools Related Companies EKF Diagnostics Competitors Intelligent Ultrasound Group Competitors Novacyt Competitors Inspiration Healthcare Group Competitors Polarean Imaging Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors MyHealthChecked Competitors Belluscura Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CREO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access